
    
      The investigators expect to show in a prospective clinical trial that, in women with a
      personal history of breast cancer, contrast-enhanced mammography substantially improves
      breast cancer detection compared to mammography with tomosynthesis, with minimal increase in
      false positives. The investigators expect a substantial increase in node-negative invasive
      cancers in particular. Because DBT will be interpreted first by one reader, and CEM will be
      interpreted first, and independently, by a second reader, there will also be an assessment of
      performance of tomosynthesis alone or CEM alone in this population.
    
  